Patients & Families
Expanded Access Policy
Reimagining the future for
RARE NEUROLOGICAL DISEASES.
Neurogene is focused on developing life-changing genetic medicines for patients and their families affected by rare, devastating neurological diseases.
Neurogene Announces FDA Clearance of IND for NGN-101 Gene Therapy to Treat CLN5 Batten Disease